Skip to main content
. 2010 Dec 31;40(12):625–631. doi: 10.4070/kcj.2010.40.12.625

Table 3.

Atherosclerosis progression during the follow-up period

graphic file with name kcj-40-625-i003.jpg

*p<0.05 vs. baseline, p<0.05 vs. placebo